Respiratory Medicine Research

The Department of Respiratory and Sleep Medicine at the Royal Prince Alfred Hospital is a leader in both translational and clinical research. Many of our researchers are recognised as national and international leaders in their field.

Our main goal is to advance our understanding and treatment of lung diseases and sleep-related disorders. We carry out diverse research including both investigator-led and industry-sponsored studies, and provide supervision and support for numerous Higher Degree by Research students.

Selected Grants

Amount awarded	Grant and project details
$9,967,326	MRFF 2020 Rapid Applied Research Translation Grant Opportunity, 2022-2027 Scaling up infectious disease point-of-care testing for Indigenous people Investigator: Fox G
$6,458,052	NHMRC, 2019-2023 Ending Tuberculosis. A cluster RCT of community-wide universal testing and treatment for latent TB infection in high prevalence settings Investigator: Fox G (CIB)
$4,773,516	NHMRC, 2022-2027 The FLIRT-TB study: A fluoroquinolone-based regimen to treat the commonest form of drug-resistant tuberculosis Investigator: Fox G (CIA)
$4,250,000	MRFF - Rapid Applied Research Translation, 2020-2025 Pathway to the Elimination of Antibiotic-Resistant Tuberculosis in the Pacific: The PEARL study Investigator: Fox G (CID)
$3,149,133	NHMRC Investigator Grant, 2022-2026 New directions in global tuberculosis control Investigator: Fox G (CIA)
$2,542,500	NHMRC Centre of Research Excellence, 2023-2028 Interstitial Lung Disease, towards individualised care Investigator: Corte TJ (CIA)
$2,498,607	NHMRC Centre of Research Excellence, 2017-2023 Centre for Research Excellence in Pulmonary Fibrosis Investigator: Corte TJ (CIA)
$2,497,940	NHMRC Centre of Research Excellence, 2019-2023 Centre of Research Excellence in Tuberculosis Control on both sides of our border Investigator: Fox G (CID)
$2,497,940	NHMRC Centre of Research Excellence, 2019-2023 Centre for Research Excellence in the accelerated implementation of new point-of-care technology for infectious diseases Investigator: Fox G (CIH)
$2,216,631	MRFF, 2021-2025 Silicosis – Harnessing new ideas to conquer the re-emergence of an ancient lung disease – The SHIELD Study Investigator: Corte T (CID)
$1,999,997	MRFF, 2023-2028 A Randomised Clinical Trial of Self Management Application in Pulmonary Fibrosis (REBUILD-SM Trial) RPA Investigator: Corte TJ
$1,954,171	NHMRC, 2023-2027 Transforming outcomes for Interstitial Lung Disease Investigator: Corte TJ (CIA)
$1,828,446	MRFF, 2020-2025 The TELO-SCOPE study: Attenuating Telomere Attrition with Danazol. Is there Scope to Dramatically Improve Health Outcomes for Adults and Children with Pulmonary Fibrosis? Investigator: Corte T (CIB)
$1,670,699	Lung Foundation Australia and Perpetual Impact, 2017-2023 Genetics Research in Idiopathic Pulmonary Fibrosis (GRIPF) Investigator: Corte TJ, Dickinson J, et al.
$1,503,718	NHMRC, 2018-2023 Ambulatory oxygen for interstitial lung disease Investigator: Corte TJ (CIC)
$980,415	MRFF 2020 Respiratory Medicine Clinical Trials Research on COVID-19, 2020-2023 IMPACT-ICO: Trials of Immuno-Modulatory Particles and Colchicine To Improve COVID-19 Outcomes Investigator: Lau E (CIC)
$658,233	NHMRC, 2022-2023 Understanding Brain Cleaning in Obstructive Sleep Apnoea Investigators: Phillips C, Postnova S, Butlin M, Wong K
$496,103	NHMRC, 2019-2023 Harnessing new mHealth technologies to Strengthen the Management of Multidrug-Resistant Tuberculosis in Vietnam: The V-SMART Trial Investigator: Fox G (CIA)
$422,345	Jannsen Research Support, 2023-2027 PHSANZ Registry Investigator: Lau E (CIA)
USD $179,032	Cystic Fibrosis Foundation, 2021-2023 Stool and symptom testing in ColoREctal Evaluation for Neoplasia in Cystic Fibrosis (SCREEN-CF) Investigator: Ooi K, Sivam S, Van Dorst J, Haber P, Mallitt K
$195,377	iCARE, 2022-2023 Silicosis Care Optimising future health care and support for people with silicosis Investigator: Holland (CIA), Corte TJ, et al.
$90,000	Lung Foundation Australia and The University of Sydney, 2021-2024 Novel diagnostic techniques in interstitial lung disease Investigator: Glenn L

Selected Previous Grants

Amount awarded	Grant and project details
$7,899,734	Canadian Institutes of Health Research (CIHR), 2015-2022 Tackling the two greatest obstacles to Tuberculosis elimination: Treatment of latent infection and drug resistant disease Investigator: Fox G
$3,230,000	NHMRC, 2015-2022 Preventing multi-drug resistant tuberculosis in a high prevalence setting: the VQUIN MDR Trial Investigator: Fox G (CIA)
$1,894,349	NHMRC/GACD, 2017-2022 An integrated health-sector strategy to combat COPD and asthma in Vietnam: A pragmatic stepped intervention cluster randomized trial Investigator: Fox G (CIA)
$1,500,000	MRFF, 2021-2022 BCG:CoVac-repurposing the existing BCG vaccine to develop a safe and effective COVID-19 candidate Investigator: Fox G (CIB)
$830,005	NHMRC, 2018-2022 Circulatory biomarkers for Idiopathic Pulmonary Fibrosis: improving patient outcomes Investigator: Corte TJ (CIB)
$108,853	NHMRC Postgraduate Scholarship, 2020-2022 The bookends to non-invasive ventilation for respiratory failure in Motor Neuron Disease - when to start it and what to do if it is not tolerated Investigator: Gray E
$92,500	Moyira Elizabeth Vine Fund for research into Schizophrenia Program, 2022 OSA and Schizophrenia Investigators: D’Rozario A, Grunstein RR, Lambert T, Yee B, Marshall N.
$10,000	Sydney Health Partners, 2022 Clinical Academic Group Investigator: Yee B

Our Publications

2022

Professor Tamera Corte

Zheng Q, Cox IA, de Graaff B, Campbell JA, Corte TJ, Glaspole I, Navaratnam V, Hopkins P, Zappala C, Ahmad H, Zhao T, Macansh S, Walters EH, Palmer AJ. The relative contribution of co-morbidities to health-related quality of life of people with idiopathic pulmonary fibrosis using the Assessment of Quality of Life-8-Dimension multi-attribute utility instrument. Qual Life Res. 2022 Dec 26. doi: 10.1007/s11136-022-03331-8. Epub ahead of print. PMID: 36572788.

Barnes H, Humphries SM, George PM, Assayag D, Glaspole I, Mackintosh JA, Corte TJ, Glassberg M, Johannson KA, Calandriello L, Felder F, Wells A, Walsh S. Machine learning in radiology: the new frontier in interstitial lung diseases. Lancet Digit Health. 2023 Jan;5(1):e41-e50. doi: 10.1016/S2589-7500(22)00230-8. Epub 2022 Dec 12. PMID: 36517410.

Barnes H, Chambers D, Grainge C, Corte TJ, Bastiampillai S, Frenkel S, Westall G, Collard H, Glaspole I. Clinical utility of a standardized chronic hypersensitivity pneumonitis exposure questionnaire. Respirology. 2022 Nov 6. doi: 10.1111/resp.14404. Epub ahead of print. PMID: 36336654.

Cox IA, de Graaff B, Ahmed H, Campbell J, Otahal P, Corte TJ, Moodley Y, Goh N, Hopkins P, Macansh S, Walters EH, Palmer AJ. The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study. Eur J Health Econ. 2022 Oct 27. doi: 10.1007/s10198-022-01538-7. Epub ahead of print. PMID: 36289130.

Lucas SEM, Raspin K, Mackintosh J, Glaspole I, Reynolds PN, Chia C, Grainge C, Kendall P, Troy L, Schwartz DA, Wood-Baker R, Walsh SLF, Moodley Y, Robertson J, Macansh S, Walters EH, Chambers D, Corte TJ, Dickinson JL. Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients. Pulmonology. 2022 Oct 7:S2531-0437(22)00213-6. doi: 10.1016/j.pulmoe.2022.09.002. Epub ahead of print. PMID: 36216738.

Glenn LM, Troy LK, Corte TJ. Diagnosing interstitial lung disease by multidisciplinary discussion: A review. Front Med (Lausanne). 2022 Sep 21;9:1017501. doi: 10.3389/fmed.2022.1017501. PMID: 36213664; PMCID: PMC9532594.

Conway Morris A, Kohler K, De Corte T, Ercole A, De Grooth HJ, Elbers PWG, Povoa P, Morais R, Koulenti D, Jog S, Nielsen N, Jubb A, Cecconi M, De Waele J; ESICM UNITE COVID investigators. Correction: Co-infection and ICU-acquired infection in COVID-19 ICU patients: a secondary analysis of the UNITE-COVID data set. Crit Care. 2022 Aug 17;26(1):249. doi: 10.1186/s13054-022-04124-8. Erratum for: Crit Care. 2022 Aug 3;26(1):236. PMID: 35978317; PMCID: PMC9383662.

Cottin V, Selman M, Inoue Y, Wong AW, Corte TJ, Flaherty KR, Han MK, Jacob J, Johannson KA, Kitaichi M, Lee JS, Agusti A, Antoniou KM, Bianchi P, Caro F, Florenzano M, Galvin L, Iwasawa T, Martinez FJ, Morgan RL, Myers JL, Nicholson AG, Occhipinti M, Poletti V, Salisbury ML, Sin DD, Sverzellati N, Tonia T, Valenzuela C, Ryerson CJ, Wells AU. Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement. Am J Respir Crit Care Med. 2022 Aug 15;206(4):e7-e41. doi: 10.1164/rccm.202206-1041ST. PMID: 35969190.

Cox IA, Campbell J, de Graaff B, Otahal P, Corte TJ, Moodley Y, Hopkins P, Macansh S, Walters EH, Palmer AJ. Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D. Qual Life Res. 2022 Aug 4. doi:10.1007/s11136-022-03205-z. Epub ahead of print. PMID: 35927542.

Conway Morris A, Kohler K, De Corte T, Ercole A, De Grooth HJ, Elbers PWG, Povoa P, Morais R, Koulenti D, Jog S, Nielsen N, Jubb A, Cecconi M, De Waele J; ESICM UNITE COVID investigators. Co-infection and ICU-acquired infection in COIVD-19 ICU patients: a secondary analysis of the UNITE-COVID data set. Crit Care. 2022 Aug 3;26(1):236. doi: 10.1186/s13054-022-04108-8. Erratum in: Crit Care. 2022 Aug 17;26(1):249. PMID: 35922860; PMCID: PMC9347163.

Humphries SM, Mackintosh JA, Jo HE, Walsh SLF, Silva M, Calandriello L, Chapman S, Ellis S, Glaspole I, Goh N, Grainge C, Hopkins PMA, Keir GJ, Moodley Y, Reynolds PN, Walters EH, Baraghoshi D, Wells AU, Lynch DA, Corte TJ. Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosis. Respirology. 2022 Dec;27(12):1045-1053. doi: 10.1111/resp.14333. Epub 2022 Jul 25. PMID: 35875881; PMCID: PMC9796832.

Molina-Molina M, Kreuter M, Cottin V, Corte TJ, Gilberg F, Kirchgaessler KU, Axmann J, Maher TM. Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a post- hoc Analysis. Front Med (Lausanne). 2022 Jun 17;9:897102. doi:10.3389/fmed.2022.897102. PMID: 35783648; PMCID: PMC9247211.

Walsh SLF, Mackintosh JA, Calandriello L, Silva M, Sverzellati N, Larici AR, Humphries SM, Lynch DA, Jo HE, Glaspole I, Grainge C, Goh N, Hopkins PMA, Moodley Y, Reynolds PN, Zappala C, Keir G, Cooper WA, Mahar AM, Ellis S, Wells AU, Corte TJ. Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-Resolution Computed Tomography. Am J Respir Crit Care Med. 2022 Oct 1;206(7):883-891. doi: 10.1164/rccm.202112-2684OC. PMID: 35696341.

Richeldi L, Azuma A, Cottin V, Hesslinger C, Stowasser S, Valenzuela C, Wijsenbeek MS, Zoz DF, Voss F, Maher TM; 1305-0013 Trial Investigators. Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis. N Engl J Med. 2022 Jun 9;386(23):2178-2187. doi: 10.1056/NEJMoa2201737. Epub 2022 May 15. PMID: 35569036.

Seth I, Bhagavata Srinivasan SP, Bulloch G, Yi DS, Frankel A, Hsu K, Passam F, Garsia R, Corte TJ. Diffuse alveolar haemorrhage as a rare complication of antiphospholipid syndrome. Respirol Case Rep. 2022 Apr 5;10(5):e0948. doi: 10.1002/rcr2.948. PMID: 35414937; PMCID: PMC8980908.

Cottin V, Tomassetti S, Valenzuela C, Walsh SLF, Antoniou KM, Bonella F, Brown KK, Collard HR, Corte TJ, Flaherty KR, Johannson KA, Kolb M, Kreuter M, Inoue Y, Jenkins RG, Lee JS, Lynch DA, Maher TM, Martinez FJ, Molina-Molina M, Myers JL, Nathan SD, Poletti V, Quadrelli S, Raghu G, Rajan SK, Ravaglia C, Remy-Jardin M, Renzoni E, Richeldi LK, Spagnolo P, Troy L, Wijsenbeek M, Wilson KC, Wuyts W, Wells AU, Ryerson CJ. Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective. Am J Respir Crit Care Med. 2022 Aug 1;206(3):247-259. doi: 10.1164/rccm.202111-2607PP. PMID: 35353660.

Zheng Q, Cox IA, Campbell JA, Xia Q, Otahal P, de Graaff B, Corte TJ, Teoh AKY, Walters EH, Palmer AJ. Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis. ERJ Open Res. 2022 Mar 14;8(1):00591-2021. doi: 10.1183/23120541.00591-2021. PMID: 35295232; PMCID: PMC8918939.

Christian K, Hey-Cunningham A, Corte T, Goh N, Jaffar J, Reynolds P, Teoh A, Troy L. Establishing CREATE: lessons learned in setting up a training environment for early-career researchers in respiratory medicine. BMC Med Educ. 2022 Mar 1;22(1):136. doi: 10.1186/s12909-022-03169-1. PMID: 35232441; PMCID: PMC8886858.

Zanframundo G, Faghihi-Kashani S, Scirè CA, Bonella F, Corte TJ, Doyle TJ, Fiorentino D, Gonzalez-Gay MA, Hudson M, Kuwana M, Lundberg IE, Mammen A, McHugh N, Miller FW, Monteccucco C, Oddis CV, Rojas-Serrano J, Schmidt J, Selva-O'Callaghan A, Werth VP, Sakellariou G, Aggarwal R, Cavagna L. Defining anti-synthetase syndrome: a systematic literature review. Clin Exp Rheumatol. 2022 Feb;40(2):309-319. doi: 10.55563/clinexprheumatol/8xj0b9. Epub 2022 Feb 25. PMID: 35225224.

Kreuter M, Maher TM, Corte TJ, Molina-Molina M, Axmann J, Gilberg F, Kirchgaessler KU, Cottin V. Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use. Adv Ther. 2022 Feb;39(2):1081-1095. doi: 10.1007/s12325-021-02009-w. Epub 2021 Dec 22. PMID: 34936057; PMCID: PMC8866297.

Cox IA, Otahal P, de Graaff B, Corte TJ, Moodley Y, Zappala C, Glaspole I, Hopkins P, Macansh S, Walters EH, Palmer AJ. Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in Australia. Respirology. 2022 Mar;27(3):209-216. doi: 10.1111/resp.14194. Epub 2021 Dec 21. PMID: 34935240.

Tikellis G, Corte TJ, Teoh AKY, Glaspole IN, Macansh S, Holland AE. Barriers and facilitators to best care for idiopathic pulmonary fibrosis in Australia. Respirology. 2022 Jan;27(1):76-84. doi: 10.1111/resp.14185. Epub 2021 Nov 15. PMID: 34783108.

Clynick B, Corte TJ, Jo HE, Stewart I, Glaspole IN, Grainge C, Maher TM, Navaratnam V, Hubbard R, Hopkins PMA, Reynolds PN, Chapman S, Zappala C, Keir GJ, Cooper WA, Mahar AM, Ellis S, Goh NS, De Jong E, Cha L, Tan DBA, Leigh L, Oldmeadow C, Walters EH, Jenkins RG, Moodley Y. Biomarker signatures for progressive idiopathic pulmonary fibrosis. Eur Respir J. 2022 Mar 31;59(3):2101181. doi: 10.1183/13993003.01181-2021. PMID: 34675050.

Hunninghake GM, Goldin JG, Kadoch MA, Kropski JA, Rosas IO, Wells AU, Yadav R, Lazarus HM, Abtin FG, Corte TJ, de Andrade JA, Johannson KA, Kolb MR, Lynch DA, Oldham JM, Spagnolo P, Strek ME, Tomassetti S, Washko GR, White ES; ILA Study Group. Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative. Chest. 2022 Feb;161(2):470-482. doi: 10.1016/j.chest.2021.06.035. Epub 2021 Jun 29. PMID: 34197782.

Teoh AKY, Holland AE, Morisset J, Flaherty KR, Wells AU, Walsh SLF, Glaspole I, Wuyts WA, Corte TJ; ILD MDM Delphi Collaborators. Essential Features of an Interstitial Lung Disease Multidisciplinary Meeting: An International Delphi Survey. Ann Am Thorac Soc. 2022 Jan;19(1):66-73. doi:10.1513/AnnalsATS.202011-1421OC. PMID: 34191689.

Professor Gregory Fox

Marks, G., Ho, J., Nguyen, P., Nguyen, T., Boi, K., Nhung, N., Nguyen, H., Nguyen, L., Garden, F., Fox, G. (2022). A Direct Measure of Tuberculosis Incidence - Effect of Community Screening. New England Journal of Medicine, 386(14), 1380-1382.

Romanowski, K., Oravec, A., Billingsley, M., Shearer, K., Gupte, A., Huaman, M., Fox, G., Golub, J., Johnston, J. (2022). A scoping review of interventions to mitigate common non-communicable diseases among people with TB. International Journal of Tuberculosis and Lung Disease, 26(11), 1016-1022.

Huang, W., Marks, G., Pham, N., Nguyen, T., Nguyen, T., Vu, V., Nguyen, V., Jan, S., Negin, J., Ngo, Q., Fox, G. (2022). A smoking quitline integrated with clinician counselling at outpatient health facilities in Vietnam: a single-arm prospective cohort study. BMC Public Health, 22(1), 739.

Redwood, L., Mitchell, E., Nguyen, T., Viney, K., Duong, L., Pham, H., Nguyen, B., Nguyen, V., Fox, G. (2022). Adaptation and validation of the Van Rie tuberculosis stigma scale in Vietnam. International Journal of Infectious Diseases, 114, 97-104.

Ngoc Yen, P., Obeid, M., Quy Chau, N., Van Giap, V., Viet Nhung, N., Yen, N., Thi Ha, B., Nguyen, T., Marks, G., Freeman, B., Negin, J., Fox, G. (2022). Behaviors and Attitudes Toward Smoking Among Health Care Workers at Health Facilities in 4 Provinces of Vietnam: A Representative Cross-Sectional Survey. Asia-Pacific Journal of Public Health, 34(1), 79-86.

Alffenaar, J., Stocker, S., Davies Forsman, L., Garcia-Prats, A., Heysell, S., Aarnoutse, R., Akkerman, O., Aleksa, A., van Altena, R., de Oata, W., Cho, J., Fox, G., Kim, H., Marais, B., et al (2022). Clinical standards for the dosing and management of TB drugs. International Journal of Tuberculosis and Lung Disease, 26(6), 483-499.

Pahlman, K., Fehross, A., Fox, G., Silva, D. (2022). Ethical health security in the age of antimicrobial resistance. BMJ Global Health, 7(1), e007407-1-e007407-11.

Velen, K., Nguyen, V., Nguyen, B., Dang, T., Nguyen, H., Vu, D., Do, T., Pham Duc, C., Nguyen, H., Pham, H., Marais, B., Britton, W., Beardsley, J., Negin, J., Fox, G., et al (2022). Harnessing new mHealth technologies to Strengthen the Management of Multidrug-Resistant Tuberculosis in Vietnam (V-SMART trial): A protocol for a randomised controlled trial. BMJ Open, 12(6).

Zawahir, M., Le, H., Nguyen, T., Beardsley, J., Dang, A., Bernays, S., Viney, K., Cao, T., Drabarek, D., Tran, H., Marais, B., Negin, J., Marks, G., Fox, G., et al (2022). Inappropriate supply of antibiotics for common viral infections by community pharmacies in Vietnam: A standardised patient survey. The Lancet Regional Health. Western Pacific, 23, 100447.

Martinez, L., Cords, O., Liu, Q., Acuna-Villaorduna, C., Bonnet, M., Fox, G., Carvalho, A., Chan, P., Croda, J., Hill, P., et al (2022). Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis. The Lancet Global Health, 10(9), e1307-e1316.

Coleman, M., Hill, J., Timeon, E., Tonganibeia, A., Eromanga, B., Islam, T., Trauer, J., Chambers, S., Christensen, A., Fox, G., Britton, W., Marais, B., et al (2022). Population-wide active case finding and prevention for tuberculosis and leprosy elimination in Kiribati: the PEARL study protocol. BMJ Open, 12(4), e055295-1-e055295-10.

Wrohan, I., Nguyen, T., Nguyen, V., Nguyen, B., Hoang, T., Nguyen, P., Velen, K., Marks, G., Fox, G. (2022). Predictors of treatment outcomes among patients with multidrug-resistant tuberculosis in Vietnam: a retrospective cohort study. BMC Infectious Diseases, 22(1), 68.

Callum, J., Nguyen, P., Martinez, E., Nguyen, V., Garden, F., Nhung, N., Nguyen, T., Nguyen, H., Nguyen, S., Luu, K., Fox, G., et al (2022). Prevalence and genetic basis of first-line drug resistance of Mycobacterium tuberculosis in Ca Mau, Vietnam. ERJ Open Research, 8(4).

Hasan, T., Nguyen, V., Nguyen, H., Nguyen, T., Le, H., Pham, C., Do, N., Nguyen, P., Beardsley, J., Marks, G., Fox, G. (2022). Retrospective Cohort Study of Effects of the COVID-19 Pandemic on Tuberculosis Notifications, Vietnam, 2020. Emerging Infectious Diseases, 28(3), 684-692.

Coorey, N., Kensitt, L., Davies, J., Keller, E., Sheel, M., Chani, K., Barry, S., Boyd, R., Denholm, J., Watts, K., Fox, G., Marais, B., Viney, K., et al (2022). Risk factors for TB in Australia and their association with delayed treatment completion. International Journal of Tuberculosis and Lung Disease, 26(5), 399-405.

Trinh, D., McKinn, S., Nguyen, A., Fox, G., Anh Thu, N., Bernays, S. (2022). Uneven stigma loads: Community interpretations of public health policies, evidence and inequities in shaping Covid-19 stigma in Vietnam. SSM - Population Health, 20.

Dr Laura Glenn

Glenn LM, Troy LK, Corte TJ. Diagnosing interstitial lung disease by multidisciplinary discussion: a review. Front Med. 2022;9:1017501.

Dr Helen Jo

Clynick B, Corte TJ, Jo HE, Stewart I, Glaspole IN, Grainge C, Maher TM, Navaratnam V, Hubbard R, Hopkins PMA, Reynolds PN, Chapman S, Zappala C, Keir GJ, Cooper WA, Mahar AM, Ellis S, Goh NS, De Jong E, Cha L, Tan DBA, Leigh L, Oldmeadow C, Walters EH, Jenkins RG, Moodley Y. Biomarker signatures for progressive idiopathic pulmonary fibrosis. Eur Respir J. 2022 Mar 31;59(3):2101181. doi: 10.1183/13993003.01181-2021. Print 2022 Mar.

Bell JM, Sivam S, Dentice RL, Dwyer TJ, Jo HE, Lau EM, Munoz PA, Nolan SA, Taylor NA, Visser SK, Yozghatlian VA, Wong KK. Quality of home spirometry performance amongst adults with cystic fibrosis. J Cyst Fibros. 2022 Jan;21(1):84-87. doi: 10.1016/j.jcf.2021.10.012. Epub 2021 Nov 10.

Walsh SLF, Mackintosh JA, Calandriello L, Silva M, Sverzellati N, Larici AR, Humphries SM, Lynch DA, Jo HE, Glaspole I, Grainge C, Goh N, Hopkins PMA, Moodley Y, Reynolds PN, Zappala C, Keir G, Cooper WA, Mahar AM, Ellis S, Wells AU, Corte TJ. Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-Resolution Computed Tomography. Am J Respir Crit Care Med. 2022 Oct 1;206(7):883-891. doi: 10.1164/rccm.202112-2684OC.

Humphries SM, Mackintosh JA, Jo HE, Walsh SLF, Silva M, Calandriello L, Chapman S, Ellis S, Glaspole I, Goh N, Grainge C, Hopkins PMA, Keir GJ, Moodley Y, Reynolds PN, Walters EH, Baraghoshi D, Wells AU, Lynch DA, Corte TJ. Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosis. Respirology. 2022 Dec;27(12):1045-1053. doi: 10.1111/resp.14333. Epub 2022 Jul 25.

Lin A, Wong K, Visser SK, Jo H, Al-Hindawi Y, Kosbab-Jackson K, Cocks M, Volovets A, Haber P, Hammond K, Taylor N, Yozghatlian V, Lau EM, Marshall NS, Aquino-Salomon T, Sivam S. Diagnosis of cystic fibrosis in adults: Australian Cystic Fibrosis Data Registry data, 2000-2019. Med J Aust. 2022 Dec 1. doi: 10.5694/mja2.51797.

Associate Professor Edmund Lau

Kearney K, Lau EM. Inherited thrombophilia in Chinese CTEPH patients: a rather common finding an uncommon condition. JACC Asia 2022;2:256-257.

Bell JM, Sivam S, Dentice RL, Dwyer TJ, Jo HE, Lau EM, Munoz PA, Nolan SA, Taylor NA, Visser SK, Yozghatlian VA, Wong KK. Quality of home spirometry perform ace amongst adults with cystic fiberosis. J Cyst Fibros 2022;21:84-87

Othman F, Bailey B, Collins N, Lau EM, Tanous D, Rao K, Celermajer D, Cordina R. Platypnoea-orthodeoxia syndrome in patent foramen ovale without pulmonary hypertension or major lung disease. J Am Heart Assoc. 2022;11:e024609.

Associate Professor Amanda Piper

Chang JL, Goldberg AN, ... Piper AJ, et al. International consensus statement on obstructive sleep apnea. Int Forum Allergy Rhinol. 2022 Sep 6.

Sivam S, Wang D, Wong KKH, Piper AJ, Zheng YZ, Gauthier G, Hockings C, McGuinness O, Menadue C, Melehan K, Cooper S, Hilmisson H, Phillips CL, Thomas RJ, Yee BJ, Grunstein RR. Cardiopulmonary coupling and serum cardiac biomarkers in obesity hypoventilation syndrome and obstructive sleep apnea with morbid obesity. J Clin Sleep Med. 2022 Apr 1;18(4):1063-1071.

Dennis CJ, Menadue C, Schneeberger T, Leitl D, Schoenheit-Kenn U, Harmer AR, Barnes DJ, Koczulla AR, Kenn K, Alison JA. Perceptions of Noninvasive Ventilation During Exercise in Noninvasive Ventilation-Naïve Patients With COPD. Respir Care. 2022 May;67(5):543-552

Qu Y, Milross M, McGuiness O, Menadue C, Piper AJ. Survey of home cleaning practices with noninvasive ventilation equipment. Cardiopulmonary Physical Therapy Journal.

Dr Sheila Sivam

Chetwood J, Koh C, Sivam S and Volovets A. Surgical Considerations in Cystic Fibrosis: What every general surgeon needs to know. ANZ Journal of Surgery. Oct 2022; 92 (10): 2425-2432.

Gudka SG, Haynes E, Scotney J, Mukherjee S, Frenkel S, Sivam S, Swieca J, Chamula K, Cunnington D and Saini B. Narcolepsy: comorbidities, complexities and future directions. Sleep Medicine Reviews. Oct 2022; 65: 101669.

Gardiner A, Volovets A, Haber P, Jo HE, Visser SK, Yozghatlian VA, Taylor N, Nolan S, Dentice R, Malouf M, Marinelli T and Sivam S. ELX/TEZ/IVA use in Cystic Fibrosis Liver Disease: Is the perspective of improved lung function worth the risk? Journal of Cystic Fibrosis. Sep 2022; 21(5): 881-884.

Bell J, Sivam S, Dentice R, Dwyer T, Jo H, Lau E, Munoz P, Nolan S, Taylor N, Visser S, Yozghatlian, and Wong, K. Quality of home spirometry performance amongst adults with Cystic Fibrosis. Journal of Cystic Fibrosis. Jan 2022; 21(1): 84-87.

Professor Paul Torzillo

Chang AB, Bell SC, Byrnes CA, Dawkins P, Holland AE, Kennedy E, King PT, Laird P, Mooney S, Morgan L, Parsons M, Poot B, Toombs M, Torzillo PJ, Grimwood K. Thoracic Society of Australia and New Zealand (TSANZ) position statement on chronic suppurative lung disease and bronchiectasis in children, adolescents and adults in Australia and New Zealand. Respirology. 2023 Apr;28(4):339-349.

Leach AJ, Wilson N, Arrowsmith B, Beissbarth J, Mulholland EK, Santosham M, Torzillo PJ, McIntyre P, Smith-Vaughan H, Chatfield MD, Lehmann D, Binks M, Chang AB, Carapetis J, Krause V, Andrews R, Snelling T, Skull SA, Licciardi PV, Oguoma VM, Morris PS. Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials. Lancet Infect Dis. 2022 Sep;22(9):1374-1387.

McCallum GB, Fong SM, Grimwood K, Nathan AM, Byrnes CA, Ooi MH, Nachiappan N, Saari N, Morris PS, Yeo TW, Ware RS, Elogius BW, Oguoma VM, Yerkovich ST, de Bruyne J, Lawrence KA, Lee B, Upham JW, Torzillo PJ, Chang AB. Extended Versus Standard Antibiotic Course Duration in Children <5 Years of Age Hospitalized With Community-acquired Pneumonia in High-risk Settings: Four-week Outcomes of a Multicenter, Double-blind, Parallel, Superiority Randomized Controlled Trial. Pediatr Infect Dis J. 2022 Jul 1;41(7):549-555.

Chang AB, Toombs M, Chatfield MD, Mitchell R, Fong SM, Binks MJ, Smith-Vaughan H, Pizzutto SJ, Lust K, Morris PS, Marchant JM, Yerkovich ST, O'Farrell H, Torzillo PJ, Maclennan C, Simon D, Unger HW, Ellepola H, Odendahl J, Marshall HS, Swamy GK, Grimwood K. Study Protocol for Preventing Early-Onset Pneumonia in Young Children Through Maternal Immunisation: A Multi-Centre Randomised Controlled Trial (PneuMatters). Front Pediatr. 2022 Jan 17;9:781168.

Associate Professor Lauren Troy

Raghu G, Remy-Jardin M, Richeldi L...Troy LK et al. Idiopathic Pulmonary Fibrosis (an update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS / ERS / JRS / ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022.

Troy LK and Williamson JP. Invited editorial: Mediastinal cryobiopsy: safe and effective but in whom and when? Lancet Respir Med. 2022.

Solomon JJ, Danoff S, Woodhead F... Troy L.. Rosas I. A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease. Lancet Respir Med. 2022.

Glenn LM, Troy LK and Corte TJ. Diagnosing Interstitial Lung Disease by Multidisciplinary Discussion: A Review. Frontiers in Medicine. 2022.

Lucas SEM, Raspin K, Mackintosh J ... Troy L et al. Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients. Pulmonology. 2022.

Korevaar DA, Colella S, Fally M, ... Troy LK, et al. European Respiratory Society guidelines on transbronchial lung cryobiopsy in the diagnosis of interstitial lung diseases. Eur Respir J. 2022.

Marinescu D-C, Raghu G, Remy-Jardin M ... Troy LK, et al. Integration and application of clinical practice guidelines for the diagnosis of idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis. Chest. 2022.

Kheir F, Becerra JPU, Bissell B, ... Troy L, et al. Transbronchial lung cryobiopsy in patients with interstitial lung disease: A systematic review. Ann Am Thorac Soc. 2022

Cottin V, Tomassetti S, Valenzuela C... Troy L et al. Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective. Am J Respir Crit Care Med. 2022.

Christian K, Hey-Cunningham A, Corte T...Troy L. Establishing CREATE: lessons learned in setting up a training environment for early-career researchers in respiratory medicine. BMC Med Ed. 2022

Dr Simone Visser

Bell JM, Sivam S, Dentice RL, Dwyer TJ, Jo HE, Lau EM, Munoz PA, Nolan SA, Taylor NA, Visser SK, Yozghatlian VA, Wong KK. Quality of home spirometry performance amongst adults with cystic fibrosis. J Cyst Fibros. 2022 Jan;21(1):84-87. doi: 10.1016/j.jcf.2021.10.012. Epub 2021 Nov 10.

Lin A, Wong K, Visser SK, Jo H, Al-Hindawi Y, Kosbab-Jackson K, Cocks M, Volovets A, Haber P, Hammond K, Taylor N, Yozghatlian V, Lau EM, Marshall NS, Aquino-Salomon T, Sivam S. Diagnosis of cystic fibrosis in adults: Australian Cystic Fibrosis Data Registry data, 2000-2019. Med J Aust. 2022 Dec 1. doi: 10.5694/mja2.51797.

Gardiner A, Volovets A, Haber P, Jo HE, Visser SK, Yozghatlian VA, Taylor N, Nolan S, Dentice R, Malouf M, Marinelli T and Sivam S. ELX/TEZ/IVA use in Cystic Fibrosis Liver Disease: Is the perspective of improved lung function worth the risk? J Cyst Fibros. Sep 2022; 21(5): 881-884

Associate Professor Keith Wong

Altree, T. J., Bartlett, D. J., Marshall, N. S., Hoyos, C. M., Phillips, C. L., Birks, C., . . . Cayanan, E. A. (2022). Predictors of weight loss in obese patients with obstructive sleep apnea. Sleep and Breathing, 26(2), 753-762.

Basheti, M. M., Tran, M., Wong, K., Gordon, C., Grunstein, R., & Saini, B. (2022). Australian consultant pharmacists' potential roles in sleep health care: Exploring a new avenue for improving the management of insomnia. Behavioral Sleep Medicine, 20(5), 622-637.

Bell, J. M., Sivam, S., Dentice, R. L., Dwyer, T. J., Jo, H. E., Lau, E. M., . . . Wong, K. K. (2022). Quality of home spirometry performance amongst adults with cystic fibrosis. Journal of Cystic Fibrosis, 21(1), 84-87.

D'Rozario, A. L., Hoyos, C. M., Wong, K. K. H., Unger, G., Kim, J. W., Vakulin, A., . . . Grunstein, R. R. (2022). Improvements in cognitive function and quantitative sleep electroencephalogram in obstructive sleep apnea after six months of continuous positive airway pressure treatment. Sleep, 45(6)

McLean, A. E. B., Kao, S. C., Barnes, D. J., Wong, K. K. H., Scolyer, R. A., Cooper, W. A., & Kohonen-Corish, M. R. J. (2022). The emerging role of the lung microbiome and its importance in non-small cell lung cancer diagnosis and treatment. Lung Cancer, 165, 124-132.

Sivam, S., Wang, D., Wong, K. K. H., Piper, A. J., Zheng, Y. Z., Gauthier, G., . . . Grunstein, R. R. (2022). Cardiopulmonary coupling and serum cardiac biomarkers in obesity hypoventilation syndrome and obstructive sleep apnea with morbid obesity. Journal of Clinical Sleep Medicine, 18(4), 1063-1071.

Vakulin, A., Green, M. A., D'Rozario, A. L., Stevens, D., Openshaw, H., Bartlett, D., . . . Rae, C. D. (2022). Brain mitochondrial dysfunction and driving simulator performance in untreated obstructive sleep apnea. Journal of Sleep Research, 31(2): e13482.

Professor Brendon Yee

Judge DJ, Miller CB, Bartlett DJ, Jomaa I, Wong KKW, Saini B, Semsarian CR, Espie CA, Kyle SD, Grunstein RR, Yee BJ, Marshall NS. Armodafinil to reduce the sleepiness related side-effects of sleep restriction therapy being used to treat insomnia disorder: An open label clinical trial pilot study compared with historical controls. J Sleep Res. 2023 Feb;32(1):e13699. doi: 10.1111/jsr.13699. Epub 2022 Aug 24. PMID: 36003019.

Aishah A, Loffler KA, Toson B, Mukherjee S, Adams RJ, Altree TJ, Ainge-Allen HW, Yee BJ, Grunstein RR, Carberry JC, Eckert DJ. One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea: A Randomized, Placebo- controlled Trial. Ann Am Thorac Soc. 2022 Dec 20. doi: 10.1513/AnnalsATS.202206-492OC.

Stranks L, Ellender CM, Wong K, Naqvi H, Grunstein R, Yee BJ, Sivam S. Retrospective cohort study of hypersomnias of central origin from two Australian tertiary sleep disorders services. Intern Med J. 2022 Aug 31. doi: 10.1111/imj.15920. Epub ahead of print. PMID: 36043439.

Hoyos CM, Cross NE, Terpening Z, D'Rozario AL, Yee BJ, LaMonica H, Marshall NS, Grunstein RR, Naismith SL. Continuous Positive Airway Pressure for Cognition in Sleep Apnea and Mild Cognitive Impairment: A Pilot Randomized Crossover Clinical Trial. Am J Respir Crit Care Med. 2022 Jun 15;205(12):1479-1482. doi: 10.1164/rccm.202111-2646LE. PMID: 35584294.

Altree TJ, Bartlett DJ, Marshall NS, Hoyos CM, Phillips CL, Birks C, Kanagaratnam A, Mullins A, Serinel Y, Wong KKH, Yee BJ, Grunstein RR, Cayanan EA. Predictors of weight loss in obese patients with obstructive sleep apnea. Sleep Breath. 2022 Jun;26(2):753-762. doi: 10.1007/s11325-021-02455-4. Epub 2021 Aug 6. PMID: 34357505.

Sivam S, Wang D, Wong KKH, Piper AJ, Zheng YZ, Gauthier G, Hockings C, McGuinness O, Menadue C, Melehan K, Cooper S, Hilmisson H, Phillips CL, Thomas RJ, Yee BJ, Grunstein RR. Cardiopulmonary coupling and serum cardiac biomarkers in obesity hypoventilation syndrome and obstructive sleep apnea with morbid obesity. J Clin Sleep Med. 2022 Apr 1;18(4):1063-1071. doi: 10.5664/jcsm.9804. PMID: 34879904; PMCID: PMC8974389.

Phillips CL, Cayanan EA, Yee BJ. Predicting Weight-Loss Effects on Obstructive Sleep Apnea and Cardiometabolic Health: In Search of the Craniofacial "Holy Grail". Am J Respir Crit Care Med. 2022 Mar 15;205(6):614-616. doi: 10.1164/rccm.202112-2750ED. PMID: 35085472.

Zheng Y, Yee BJ, Wong K, Grunstein R, Piper A. A pilot randomized trial comparing CPAP vs bilevel PAP spontaneous mode in the treatment of hypoventilation disorder in patients with obesity and obstructive airway disease. J Clin Sleep Med. 2022 Jan 1;18(1):99-107. doi: 10.5664/jcsm.9506. PMID: 34170241; PMCID: PMC8807907.

2021

Ainge-Allen H, Yee B, Ip M. Sleep 2020; Contemporary Concise Review on Sleep. Respirology 2021 26(7) 700-706

Aronson KI, Danoff SK, Russell AM, Ryerson CJ, Suzuki A, Wijsenbeek MS, Bajwah S, Bianchi P, Corte TJ, Lee JS, Lindell KO, Maher TM, Martinez FJ, Meek PM, Raghu G, Rouland G, Rudell R, Safford MM, Sheth JS, Swigris JJ. Patient- centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2021 Jul 15;204(2):e3-e23. doi: 10.1164/rccm.202105-1193ST. Erratum in: Am J Respir Crit Care Med. 2021 Sep 1;204(5):616. PMID: 34283696; PMCID: PMC8650796.

Barnes, H, Troy L, Lee CT, Sperling A, Strek M, Glaspole I. Hypersensitivity pneumonitis: current concepts in pathogenesis, diagnosis and treatment. Allergy. 2021.

Bell J*, Sivam S* (Co-first author), Dentice R, Dwyer T, Jo H, Lau E, Munoz P, Nolan S, Taylor N, Visser S, Yozghatlian, and Wong, K. Quality of home spirometry performance amongst adults with Cystic Fibrosis. Journal of Cystic Fibrosis. Accepted for publication October 2021.

Chapman JL. Hoyos CM, Killick R, Sutherland K, Cistulli PA, Zwar N, Yee BJ, Marks G, Grunstein RR, Wong KHK on behalf of the Sydney-OSA-GP Study Investigators. Development and validation of a model for diagnosis of obstructive sleep apnea in primary care. Respirology 2021

Christian K, Hey-Cunningham A, Corte T...Troy L. Establishing CREATE: lessons learned in setting up a training environment for early-career researchers in respiratory medicine. BMC Med Ed. 2022

Clynick B, Corte TJ, Jo HE, Stewart I, Glaspole IN, Grainge C, Maher TM, Navaratnam V, Hubbard R, Hopkins PMA, Reynolds PN, Chapman S, Zappala C, Keir GJ, Cooper WA, Mahar AM, Ellis S, Goh NS, De Jong E, Cha L, Tan DBA, Leigh L, Oldmeadow C, Walters EH, Jenkins RG, Moodley Y. Biomarker signatures for progressive idiopathic pulmonary fibrosis. Eur Respir J. 2021 Oct 21:2101181. doi: 10.1183/13993003.01181-2021. Epub ahead of print. PMID: 34675050.

Cooper WA, Mahar A, Myers JL, Grainge C, Corte TJ, Williamson JP, Lau EMT, Raghu G, Troy LKT. In reply. Arch Pathol Lab Med. 2021.

Cooper WA, Mahar A, Myers JL, Grainge C, Corte TJ, Williamson JP, Vallely MP, Lai S, Mulyadi E, Torzillo PJ, Phillips MJ, Lau EMT, Raghu G, Troy LK. Cryobiopsy for identification of usual interstitial pneumonia and other interstitial lung disease features: further lessons from COLDICE. Am J Respir Med Crit Care. 2021 (editorialised).

Corte TJ, Lancaster L, Swigris JJ, Maher TM, Goldin JG, Palmer SM, Suda T, Ogura T, Minnich A, Zhan X, Tirucherai GS, Elpers B, Xiao H, Watanabe H, Smith RA, Charles ED, Fischer A. Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA<sub>1</sub>) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD). BMJ Open Respir Res. 2021 Dec;8(1):e001026. doi: 10.1136/bmjresp-2021-001026. PMID: 34969771; PMCID: PMC8718498.

Cottin V, Tomassetti S, Valenzuela C... Troy L et al. Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective. Am J Respir Crit Care Med. 2022.

Cox IA, de Graaff B, Ahmed H, Campbell J, Otahal P, Corte TJ, Glaspole I, Moodley Y, Goh N, Macansh S, Walters EH, Palmer AJ. The impact of idiopathic pulmonary fibrosis on health state utility values: evidence from Australia. Qual Life Res. 2021 Sep;30(9):2615-2632. doi: 10.1007/s11136-021-02879-1. Epub 2021 May 17. PMID: 33999322.

Cox IA, de Graaff B, Corte TJ, Glaspole I, Chambers DC, Moodley Y, Teoh A, Walters EH, Palmer AJ. Recent trends in pirfenidone and nintedanib use for idiopathic pulmonary fibrosis in Australia. Aust Health Rev. 2021 Dec;45(6):718-727. doi: 10.1071/AH20337. PMID: 34706811.

Dinh MM, Hutchings O, Bein KJ, Shaw J, Raut A, Berendsen S, Jagers D, Fox GJ, Edwards J, Britton WJ. Emergency department patients from quarantine hotels in Sydney Australia during the COVID19 outbreak - an analysis of presentation types and outcomes. Med J Aust 2021 214(10):473-4).*

Dowman LM, May AK, Hill CJ, Bondarenko J, Spencer L, Morris NR, Alison JA, Walsh J, Goh NSL, Corte T, Glaspole I, Chambers DC, McDonald CF, Holland AE. High intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: protocol for a randomised controlled trial. BMC Pulm Med. 2021 Nov 10;21(1):361. doi: 10.1186/s12890-021-01704-2. PMID: 34758808; PMCID: PMC8582173.

Drennan P, Thoma Y, Barry L, Sivam S and van Hal SJ. Bayesian forecasting for intravenous tobramycin dosing in adults with Cystic Fibrosis using one versus two serum concentrations in a dosing interval. Therapeutic Drug Monitoring 2021; 43(4): 505-511.

Duong TMN, Le TV, Tran KLH, Nguyen PT, Nguyen BPT, Nguyen TA, Nguyen HLP, Nguyen BNT, Fisher MC, Rhodes J, Marks G, Fox GJ, Chen SC-A, Walsh MG, Barrs VR, Talbot J, Halliday CL, Sorrell TC, Day JN, Beardsley J. Azole-resistant Aspergillus fumigatus is highly prevalent in the environment of Vietnam, with marked variability by land use type. Environ Microbiol 07 Jul 2021. https://doi.org/10.1111/1462-2920.15660.

Fawcett L, Wakefield C, Sivam S, Middleton P, Wark P, Widger J, Jaffe A, Waters S. Avatar acceptability: Views from the Australian Cystic Fibrosis community on the use of personalised organoid technology to guide treatment decisions. ERJ Open Research 2021; 7(1): 00448-2020.

Fox GJ, Johnston JC, Nguyen TA, Majumdar SS, Denholm JT, Alsdurf H, Nguyen CB, Marks GB, Velen K. Active case-finding in contacts of people with TB. Int J Tuberc Lung Dis 2021 25(2): 95-105.*

Fox GJ, Nguyen TA, Coleman M, Trajman A, Velen K, Marais BM. Implementing tuberculosis preventive treatment in high-prevalence settings. Int J Infect Dis 2021. https://doi.org/10.1016/j.ijid.2021.02.094

Glenn LM, Pugashetti JV, Oldham J, Corte TJ. Interstitial pneumonia with autoimmune features: from research classification to diagnosis. Curr Opin Pulm Med. 2021 Sep 1;27(5):374-387. doi: 10.1097/MCP.0000000000000802. PMID: 34183525.

Gray EL, Forrest P, Southwood TJ, Totaro RJ, Plunkett BT, Torzillo PJ. Long-term outcomes of adults with acute respiratory failure treated with veno-venous extracorporeal membrane oxygenation. Journal Anaesthesia and Intensive Care, 2021;49(6):477-485

Guler SA, Corte TJ. Interstitial Lung Disease in 2020: A History of Progress. Clin Chest Med. 2021 Jun;42(2):229-239. doi: 10.1016/j.ccm.2021.03.001. PMID: 34024399.

Hasan T, Beardsley J, Marais BJ, Nguyen TA, Wood N, Fox GJ. The implementation of mass-vaccination against SARS-CoV-2: a systematic review of existing strategies and guidelines. Vaccines (Basel). 2021;9(4).

Hasan T, Pham TN, Nguyen TA, Le HTT, Van DL, Dang T, Van TD, Pham YN, Nguyen VH, Tran GL, Nguyen VTC, Nguyen TT, Truong VQ, Dao TH, Thanh CL, Truong NT, Ho HT, Le PT, Nguyen TT, Luu VV, Nguyen VD, Toelle BG, Marks GB, Fox GJ. Sero-prevalence of SARS-CoV-2 antibodies in high-risk populations in Vietnam. Int J Envir Res Pub H 2021 2021, 18(12), 6353; https://doi.org/10.3390/ijerph18126353.

Huang WC, Pham NY, Nguyen TA, Vu VG, Ngo QC, Nguyen VN, Freeman B, Jan S, Negin J, Marks GB, Fox GJ. Smoking behaviour among adult patients presenting to health facilities in four provinces of Vietnam. BMC Public Health. 2021 May 1;21(1):845. doi: 10.1186/s12889-021-10880-z. PMID: 33933063; PMCID: PMC8088640.

Jee AS, Parker MJS, Bleasel JF, Troy LK, Lau EM, Jo HE, Teoh AKY, Adelstein S, Webster S, Corte TJ. Baseline characteristics and survival of an Australian Interstitial Pneumonia with Autoimmune Features Cohort. Respiration. 2021.

Jee AS, Parker MJS, Bleasel JF, Troy LK, Lau EM, Jo HE, Teoh AKY, Webster S, Adelstein S, Corte TJ. Diagnosis of myositis-associated interstitial lung disease: Utility of the myositis autoantibody line immunoassay. Respir Med. 2021 Oct;187:106581. doi: 10.1016/j.rmed.2021.106581. Epub 2021 Aug 21. PMID: 34454312.

Jee AS, Parker MJS, McGill N, Bleasel JF, Webster S, Troy LK, Corte TJ. Nailfold capillaroscopy by smartphone-dermatoscope for connective tissue disease diagnosis in interstitial lung disease: a prospective observational study. ERJ Open Res. 2021 Nov 8;7(4):00416-2021. doi: 10.1183/23120541.00416-2021. PMID: 34760999; PMCID: PMC8573234.

Jee AS, Sheehy R, Hopkins P, Corte TJ, Grainge C, Troy LK, Symons K, Spencer LM, Reynolds PN, Chapman S, de Boer S, Reddy T, Holland AE, Chambers DC, Glaspole IN, Jo HE, Bleasel JF, Wrobel JP, Dowman L, Parker MJS, Wilsher ML, Goh NSL, Moodley Y, Keir GJ. Diagnosis and management of connective tissue disease- associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand. Respirology. 2021 Jan;26(1):23-51. doi: 10.1111/resp.13977. Epub 2020 Nov 24. PMID: 33233015; PMCID: PMC7894187.

Kanjrawi AA, Mathers L, Webster S, Corte TJ, Carey S. Nutritional status and quality of life in interstitial lung disease: a prospective cohort study. BMC Pulm Med. 2021 Feb 5;21(1):51. doi: 10.1186/s12890-021-01418-5. PMID: 33546667; PMCID: PMC7863253.

Kheir F, Becerra JPU, Bissell B, Ghazipura M, Herman D, Hon SM, Hossain T, Khor YH, Knight SL, Kreuter M, Macrea M, Mammen MJ, Martinez FJ, Poletti V, Troy L, Raghu G, Wilson KC. Transbronchial lung cryobiopsy in patients with interstitial lung disease: A systematic review. Ann Am Thorac Soc. (In press). 2022

Kheir F, Becerra JPU, Bissell B, Ghazipura M, Herman D, Hon SM, Hossain T, Khor YH, Knight SL, Kreuter M, Macrea M, Mammen MJ, Martinez FJ, Poletti V, Troy L, Raghu G, Wilson KC. Use of a genomic classifier in patients with interstitial lung disease: a systematic review. Ann Am Thorac Soc. (In press). 2021.

Lam T, Dang DA, Tran HH, Do Van D, Le H, Negin J, Jan S, Marks G, Nguyen TA, Fox GJ, Beardsley J. What are the most effective community-based antimicrobial stewardship interventions in low and middle incomes countries? A narrative review. J Antimicrob Chemoth 2021;76(5):1117-29.

Lea, T., Grealy, L., Moskos, M., Brambilla, A., King, S., Habibis, D., Benedict, R., Phibbs, P., Sun, C., Torzillo, P. (2021). Sustainable Indigenous housing in regional and remote Australia. Australian Housing and Urban Research Institute Final Report, 368, 1-107.

Leach, A., Mulholland, E., Santosham, M., Torzillo, P., McIntyre, P., Smith-Vaughan, H., Wilson, N., Arrowsmith, B., Beissbarth, J., Chatfield, M., et al (2021). Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial. Vaccine: X, 7, 100086.

Leach, A., Mulholland, E., Santosham, M., Torzillo, P., McIntyre, P., Smith-Vaughan, H., Wilson, N., Arrowsmith, B., Beissbarth, J., Chatfield, M., et al (2021). Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial. BMC Pediatrics, 21(1), 117.

Liu G, Philp AM, Corte T, Travis MA, Schilter H, Hansbro NG, Burns CJ, Eapen MS, Sohal SS, Burgess JK, Hansbro PM. Therapeutic targets in lung tissue remodelling and fibrosis. Pharmacol Ther. 2021 Sep;225:107839. doi: 10.1016/j.pharmthera.2021.107839. Epub 2021 Mar 25. PMID: 33774068.

Mackintosh JA, Glenn L, Barnes H, Dunn E, Bancroft S, Reddy T, Teoh AKY, Troy L, Jo H, Geis M, Glaspole I, Grainge C, Corte TJ, Chambers DC, Hopkins P. Benefits of a virtual interstitial lung disease multidisciplinary meeting in the face of COVID-19. Respirology. 2021 Jun;26(6):612-615. doi: 10.1111/resp.14062. Epub 2021 Apr 19. PMID: 33871150; PMCID: PMC8251432.

Mackintosh JA, Pietsch M, Lutzky V, Enever D, Bancroft S, Apte SH, Tan M, Yerkovich ST, Dickinson JL, Pickett HA, Selvadurai H, Grainge C, Goh NS, Hopkins P, Glaspole I, Reynolds PN, Wrobel J, Jaffe A, Corte TJ, Chambers DC. TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis. BMJ Open Respir Res. 2021 Dec;8(1):e001127. doi: 10.1136/bmjresp-2021-001127. PMID: 34857525; PMCID: PMC8640666.

McLean AEB, Gagnadoux F, Yee BJ. Blowing away fatty Liver: Mission Impossible? AJRCCM 2021 203(4):412-413

McLean, A., Webster, S., Fry, M., Lau, E., Corte, P., Torzillo, P., Troy, L., Jo, H., Geis, M., Rhodes, J., Spencer, L., Corte, T., et al (2021). Priorities and expectations of patients attending a multidisciplinary interstitial lung disease clinic. Respirology, 26(1), 80-86.

Nambiar S, Clynick B, How BS, King A, Walters EH, Goh NS, Corte TJ, Trengove R, Tan D, Moodley Y. There is detectable variation in the lipidomic profile between stable and progressive patients with idiopathic pulmonary fibrosis (IPF). Respir Res. 2021 Apr 9;22(1):105. doi: 10.1186/s12931-021-01682-3. PMID: 33836757; PMCID: PMC8033725.

Nambiar S, Tan DBA, Clynick B, Bong SH, Rawlinson C, Gummer J, Corte TJ, Glaspole I, Moodley YP, Trengove R. Untargeted metabolomics of human plasma reveal lipid markers unique to chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Proteomics Clin Appl. 2021 May;15(2-3):e2000039. doi: 10.1002/prca.202000039. Epub 2021 Mar 18. PMID: 33580915.

Nathan SD, Cottin V, Behr J, Hoeper MM, Martinez FJ, Corte TJ, Keogh AM, Leuchte H, Mogulkoc N, Ulrich S, Wuyts WA, Yao Z, Ley-Zaporozhan J, Müller-Lisse UG, Scholle FD, Brüggenwerth G, Busse D, Nikkho S, Wells AU. Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study. J Heart Lung Transplant. 2021 Jun;40(6):494-503. doi: 10.1016/j.healun.2021.02.006. Epub 2021 Feb 19. PMID: 33744088.

Noth I, Cottin V, Chaudhuri N, Corte TJ, Johannson KA, Wijsenbeek M, Jouneau S, Michael A, Quaresma M, Rohr KB, Russell AM, Stowasser S, Maher TM; INMARK trial investigators. Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial. Eur Respir J. 2021 Jul 8;58(1):2001518 doi: 10.1183/13993003.01518-2020. PMID: 33419890; PMCID: PMC8264778.

Philip J, Collins A, Smallwood N, Chang YK, Mo L, Yang IA, Corte T, McDonald CF, Hui D. Referral criteria to palliative care for patients with respiratory disease: a systematic review. Eur Respir J. 2021 Oct 21;58(4):2004307. doi: 10.1183/13993003.04307-2020. PMID: 33737407.

Piper A. Long-term ventilatory support for children: there's no place like home. Respirology. 2021;26(10):902-903

Piper AJ. Initiating home non-invasive ventilation: How well are we doing? Respirology. 2021; 26(11):1014-1015

Polke M, Kondoh Y, Wijsenbeek M, Cottin V, Walsh SLF, Collard HR, Chaudhuri N, Avdeev S, Behr J, Calligaro G, Corte TJ, Flaherty K, Funke-Chambour M, Kolb M, Krisam J, Maher TM, Molina Molina M, Morais A, Moor CC, Morisset J, Pereira C, Quadrelli S, Selman M, Tzouvelekis A, Valenzuela C, Vancheri C, Vicens- Zygmunt V, Wälscher J, Wuyts W, Bendstrup E, Kreuter M. Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and Non-specialised ILD Centres Around the World. Front Med (Lausanne). 2021 Sep 27;8:699644. doi: 10.3389/fmed.2021.699644. PMID: 34646836; PMCID: PMC8502934.

Proudman SM, Corte TJ. Are serum biomarkers useful in the management of systemic sclerosis-associated interstitial lung disease? Respirology. 2021 May;26(5):406-408. doi: 10.1111/resp.14017. Epub 2021 Feb 20. PMID: 33611844.

Redwood L, Mitchell EHM, Viney KA, Snow K, Nguyen TA, Duong L, Nguyen VN, Fox GJ. Depression, stigma and quality-of-life in people with drug-susceptible TB and drug-resistant TB in Vietnam. Int J Tuberc Lung Dis 2021;25(6):461-7.

Redwood L, Mitchell EMH, Nguyen TA, Viney K, Nguyen VN, Fox GJ. Psychometric evaluation of a new drug-resistant tuberculosis stigma scale. J Clin Epi 2021 133:101-110. https://doi.org/10.1016/j.jclinepi.2021.01.007 *

Roswell L, Wu J, Yee BJ, Wong KKH, Sivam S, Somogyi A, Grunstein RR, Wang D. The Effect of Acute Morphine on Sleep: Is There a Genetic Effect?-an RCT Study J Sleep Res 2021

Rowsell L, Wu J, Yee BJ, Wong KKH, Sivam S, Somogyi AA, Grunstein RR and Wang D. The Effect of Acute Morphine on Sleep in Male Patients Suffering from Sleep Apnea: Is There a Genetic Effect? - an RCT Study. Journal of Sleep Research 2021; 30(4): e13249.

Ryerson CJ, Corte TJ, Myers JL, Walsh SLF, Guler SA. A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease. Eur Respir J. 2021 Dec 16;58(6):2100276. doi: 10.1183/13993003.00276-2021. PMID: 34140296; PMCID: PMC8674517.

Sivam S, Chamula K, Frenkel S, Mukherjee S, Swieca J and Saini B on behalf if the Australasian Sleep Association. The Challenge of Providing Access to First-Line Medicines for Patients with Narcolepsy in Australia.https://www.aph.gov.au/Parliamentary_Business/Committees/House/Health_A…. 2021.

Sivam S, Chamula K, Frenkel S, Swieca J and Saini B. Perspective: Narcolepsy Management in Australia: Time to Wake Up. Med J Aust. 2021; 215 (2): 62-63.

Sivam S, Singer R and Yee BJ. Editorial: Does CPAP improve CKD in OSA? It's still a maybe. Chest 2021;159 (5):1717-1718.

Sivam S, Singer R, Yee B. Effect of CPAP therapy on kidney function in patients with chronic kidney disease; a pilot randomised controlled trial. Chest 2021 159(5)1717-1718

Sivam S, Wang D, Wong K, Piper A, Zheng, Yi Zhong, Gauthier G, Hocking C, McGuinness O, Menadue C, Melehan K, Hilmisson H, Philips C, Thomas J, Yee B, Grunstein R. Cardiopulmonary Coupling and serum cardiac Biomarkers in Obesity Hypoventilation Syndrome and Obstructive Sleep Apnea with Morbid obesity. JCSM 2021

Sivam S, Yee BJ, Chadburn SJ, Piper AJ, Hanly P, Wang D, Wong K, Grunstein RR. Prevalence of Chronic Kidney Disease in Obesity Hypoventilation Syndrome and Obstructive Sleep Apnea and Obesity. Sleep Med 2021

Smith-Vaughan, H., Cheng, A., Tabrizi, S., Wurzel, D., Beissbarth, J., Leach, A., Morris, P., Binks, M., Torzillo, P., Chang, A., et al (2021). Absence of human papillomavirus in nasopharyngeal swabs from infants in a population at high risk of human papillomavirus infection. Global Journal of Emerging Market Economies, 5(2), 136-139.

Soon H, Sweeney S, Mudzengi D, Creswell J, Menzies NA, Fox GJ, MacPherson P, Dowdy DW. Determining the Value of Tuberculosis Active Case Finding: Current Evidence and Methodological Considerations for Economic Evaluation. Int J Tuber Lung Dis 2021 25(3) 171-181. http://dx.doi.org/10.5588/ijtld.20.0565.

Sutherland K, Yee BJ, Kairaitis K, Wheatley J, de Chazal P, Cistulli PA. A Phenotypic Approach for Personalised Management of Obstructive Sleep Apnea. Curr Otor Reports 2021 9:3 223-237

Teoh AKY, Corte TJ. Contemporary Concise Review 2020: Interstitial lung disease. Respirology. 2021 Jun;26(6):604-611. doi: 10.1111/resp.14063. Epub 2021 Apr 28. PMID: 33913200.

Thu-Anh N, Yen PN, Nhung DP, Thao NH, Toan DT, Giap VV, Marks GB, McKinn S, Joel N, Bernays S, Fox GJ. Factors affecting healthcare pathways for chronic lung disease management in Vietnam: a qualitative study on patients' perspectives. BMC Pub Health. 21(1):1145. 10.1186/s12889-021-11219-4

Tikellis G, Tong A, Lee JYT, Corte TJ, Hey-Cunningham AJ, Bartlett M, Crawford T, Glaspole I, Price J, Maloney J, Holland AE. Top 10 research priorities for people living with pulmonary fibrosis, their caregivers, healthcare professionals and researchers. Thorax. 2021 Jun;76(6):575-581. doi: 10.1136/thoraxjnl-2020-215731. Epub 2020 Dec 4. PMID: 33277429.

Tong, A., Sorrell, T., Black, A., Caillaud, C., Chrzanowski, W., Li, E., Martinez-Martin, D., McEwan, A., Wang, R., Motion, A., Casas Bedoya, A., Huang, J., Azizi, L., Eggleton, B., Andersen, T., Baillie, A., Barratt, A., Boehm, C., Britton, P., Chadban, S., Chow, C., Fleming, S., Fox, G., Gordon, L., Ho-Baillie, A., Howell, M., Hickie, I., Hunt, N., Iredell, J., Jin, C., Kairaitis, K., Kavehei, O., Kritharides, L., Leon-Saval, S., Lindley, R., Maguire, S., McCluskey, M., McKay, N., Mifsud, G., Palomba, S., Pettigrew, A., Postnova, S., Prinable, J., Rabeau, J., Rees, M., Richmond, K., Scholes Robertson, N., Seppelt, I., Shaw, T., Sintchenko, V., Snelling, T., Teixeira-Pinto, A., Tovey, E., Tuniz, A., Varamini, P., Wang, A., Wang, K., Wise, S., Zoellner, H. (2021). Research priorities for COVID-19 sensor technology. Nature Biotechnology, 39(2), 144-153

Wang D, Yee BJ, Chung F, Grunstein RR. Chronic opioid use and Central Sleep Apnea, Where are we now and where to go?-A State of the Art Review. Anaesthesia and Analgesia 2021 132(5):1244-1253

Zhao A, Gudmundsson E, Mogulkoc N, Jones MG, van Moorsel C, Corte TJ, Romei C, Savas R, Brereton CJ, van Es HW, Jo H, De Liperi A, Unat O, Pontoppidan K, van Beek F, Veltkamp M, Hopkins P, Moodley Y, Taliani A, Tavanti L, Gholipour B, Nair A, Janes S, Stewart I, Barber D, Alexander DC, Wells AU, Jacob J. Mortality in combined pulmonary fibrosis and emphysema patients is determined by the sum of pulmonary fibrosis and emphysema. ERJ Open Res. 2021 Aug 23;7(3):00316-2021. doi: 10.1183/23120541.00316-2021. PMID: 34435039; PMCID: PMC8381266.

Zheng Y, Piper A, Sivam S, Wong K, Grunstein R, Phillips C, Yee BJ. Cardiovascular Disease in Obesity Hypoventilation Syndrome-A review of Potential Mechanism and Effects of Therapy. Sleep Medicine Review 2021

Zheng Y, Yee BJ, Wong K, Grunstein R, Piper A. A pilot randomized trial comparing CPAP versus bilevel PAP spontaneous mode in the treatment of hypoventilation disorder in patients with obesity and obstructive airway disease. J Clin Sleep Med. 2021. doi: 10.5664/jcsm.9506. 5. Dennis CJ, Menadue C, Schneeberger T, Leitl D, Schoenheit-Kenn U, Hoyos CM, Harmer AR, Barnes DJ, Koczulla AR, Kenn K, Alison JA. Bilevel Noninvasive Ventilation During Exercise Reduces Dynamic Hyperinflation and Improves Cycle Endurance Time in Severe to Very Severe COPD. Chest 2021;160(6):2066-2079

Zheng Y, Yee BJ, Wong K, Grunstein R, Piper. A pilot randomised trial comparing CPAP versus Bi-level PAP in the treatment of hypoventilation disorder in obese patients with obstructive airways disease. JCSM 2021

Zheng YZ, Phillips C, Sivam S, Wong KKH, Grunstein RR, Piper AP and Yee BJ. Cardiovascular Disease in Obesity Hypoventilation Syndrome - A Review of Potential Mechanisms and Effects of Therapy. Sleep Medicine Reviews Aug 2021;60; 101530.

Zumla A, Chakaya J, Khan M, Fatima R, Wejse C, Al-Abri S, Fox GJ, Nachega J, Kapata N, Knipper M, Orcutt M, Gosce L, Abubakar I, Nagu TJ, Mugusi F, Gordon AK, Shanmugam S, Bachmann N, Lam C, Sintchenko V, Rudolf F, Amanullah F, Kock R, Haider N, Lipman M, King M, Maeurer M, Goletti D, Petrone L, Yaquoob A, Tiberi S, Ditiu L, Sahu S, Marais B, Petersen E. 'THE CLOCK IS TICKING' - and the world is running out of time to deliver the United Nations commitments to End TB due to the COVID-19 pandemic. Int J Infect Dis. 2021. 10.1016/j.ijid.2021.03.046 *

2020

Ainge-Allen, H., Yee, B. (2020). A moment on the lips, a lifetime on the mask: weight-loss programs and sleep apnea. The Journal of Clinical Sleep Medicine, 16(4), 471-472.

Alsdurf, H., Oxlade, O., Adjobimey, M., Ahmad Khan, F., Bastos, M., Bedingfield, N., Benedetti, A., Boafo, D., Buu, T., Chiang, L., Fox, G., et al (2020). Resource implications of the latent tuberculosis cascade of care: A time and motion study in five countries. BMC Health Services Research, 20(1), 341.

Anderson, J., Lau, E., Lavender, M., Benza, R., Celermajer, D., Collins, N., Corrigan, C., Dwyer, N., Feenstra, J., Horrigan, M., et al (2020). Retrospective Validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort. Chest, 157(1), 162-172.

Anderson, J., Lavender, M., Lau, E., Celermajer, D., Collins, N., Dwyer, N., Feenstra, J., Horrigan, M., Keating, D., Keogh, A., et al (2020). Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and Challenges. Heart, Lung, and Circulation, 29(10), 1459-1468.

Clynick, B., Jo, H., Corte, T., Glaspole, I., Grainge, C., Hopkins, P., Reynolds, P., Chapman, S., Haydn Walters, E., Zappala, C., Cooper, W., Mahar, A., et al (2020). Circulating RNA differences between patients with stable and progressive idiopathic pulmonary fibrosis. European Respiratory Journal, 56(3), 1902058.

Cocozza, A., Linh, N., Nathavitharana, R., Ahmad, U., Jaramillo, E., Gargioni, G., Fox, G. (2020). An assessment of current tuberculosis patient care and support policies in high-burden countries. International Journal of Tuberculosis and Lung Disease, 24(1), 36-42.

Cox, I., Arriagada, N., De Graaff, B., Corte, T., Glaspole, I., Lartey, S., Walters, E., Palmer, A. (2020). Health-related quality of life of patients with idiopathic pulmonary fibrosis: A systematic review and meta-analysis. European Respiratory Review, 29(158), 1-22.

Fox, G., Nguyen, C., Nguyen, T., Tran, P., Marais, B., Graham, S., Nguyen, B., Velen, K., Mason, P., Britton, W., Marks, G., et al (2020). Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial. BMJ Open, 10(1), e033945.

Fox, G., Trauer, T., McBryde, E. (2020). Modelling the impact of COVID-19 on intensive care services in New South Wales. Medical Journal of Australia, 212(10), 468-469

Glenn, L., Corte, T. (2020). Diagnosing idiopathic pulmonary fibrosis: Has the time for surgical lung biopsy passed? Respirology, 25(11), 1112-1113.

Ho, J., Bokil, N., Nguyen, P., Nguyen, T., Liu, M., Hare, N., Fox, G., Saunders, B., Marks, G., Britton, W. (2020). A transcriptional blood signature distinguishes early tuberculosis disease from latent tuberculosis infection and uninfected individuals in a Vietnamese cohort. Journal of Infection, 81(1), 72-80.

Holland, A., Corte, T., Chambers, D., Palmer, A., Ekstrm, M., Glaspole, I., Goh, N., Hepworth, G., Khor, Y., Hoffman, M., Troy, L., et al (2020). Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX trial): A randomised controlled trial. BMJ Open, 10(12), e040798.

Joshi, E., Nanayakkara, B., Barnes, D., Troy, L. (2020). Precision Medicine in Lung Cancer. European Medical Journal Oncology, 1, 1-12.

Khou, V., Anderson, J., Strange, G., Corrigan, C., Collins, N., Celermajer, D., Dwyer, N., Feenstra, J., Horrigan, M., Keating, D., Lau, E., et al (2020). Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registry. Respirology, 25(8), 863-871.

Kreuter, M., Polke, M., Walsh, S., Krisam, J., Collard, H., Chaudhuri, N., Avdeev, S., Behr, E., Calligaro, G., Corte, T., et al (2020). Acute exacerbation of idiopathic pulmonary fibrosis: International survey and call for harmonisation. European Respiratory Journal, 55(4), 1901760.

Lau, E., Grainge, C., Williamson, J., Corte, T., Cooper, W., Phillips, M., Torzillo, P., Vallely, M., Raghu, G., Troy, L. (2020). Methodologies of COLDICE and Cryo-PID studies: details make the difference. Annals of Translational Medicine, 8(12), 781.

Lee, J., Tikellis, G., Corte, T., Goh, N., Keir, G., Spencer, L., Sandford, D., Khor, Y., Glaspole, I., Price, J., Hey-Cunningham, A., Teoh, A., et al (2020). The supportive care needs of people living with pulmonary fibrosis and their caregivers: A systematic review. European Respiratory Review, 29(156), 190125.

Lu, M., Yee, B., Fitzgerald, D. (2020). Transition to adult care in sleep medicine. Paediatric Respiratory Reviews, 33(0), 9-15.

Maher, T., Corte, T., Fischer, A., Kreuter, M., Lederer, D., Molina-Molina, M., Axmann, J., Kirchgaessler, K., Samara, K., Gilberg, F., et al (2020). Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial. The Lancet Respiratory Medicine, 8(2), 147-157.

Marais, B., Chakaya, J., Swaminathan, S., Fox, G., Ehtesham, N., Ntoumi, F., Zijenah, L., Maurer, M., Zumla, A. (2020). Tackling long-term morbidity and mortality after successful tuberculosis treatment. The Lancet Infectious Diseases, 20(6), 641-642.

Marks, G., Nguyen, N., Fox, G. (2020). Community-wide screening for tuberculosis. New England Journal of Medicine, 382(12), 1186.

Mason, P., Lyttleton, C., Marks, G., Fox, G. (2020). The technological imperative in tuberculosis care and prevention in Vietnam. Neurogastroenterology and Motility, 15(2), 307-320.

Mok, Y., Melehan, K., Phillips, C., Yee, B., Miller, C., Grunstein, R., Bartlett, D., Liu, P., Wong, K., Hoyos, C. (2020). Does CPAP treat depressive symptoms in individuals with OSA? An analysis of two 12-week randomized sham CPAP-controlled trials. Sleep Medicine, 73, 11-14.

Moore, I., Wrobel, J., Rhodes, J., Lin, Q., Webster, S., Jo, H., Troy, L., Grainge, C., Glaspole, I., Corte, T. (2020). Australasian interstitial lung disease registry (AILDR): Objectives, design and rationale of a bi-national prospective database. BMC Pulmonary Medicine, 20(1), 257.

Nanayakkara, B., Lau, E., Yee, B., Gauthier, G., Melehan, K., Celermajer, D., Cordina, R. (2020). Sleep disordered breathing in adults living with a Fontan circulation and CPAP titration protocol. International Journal of Cardiology, 317, 70-74.

Nguyen, T., Nguyen, T., Luu, B., Le, T., Nguyen, V., Nguyen, K., Duong, K., Nguyen, H., Nguyen, N., Fox, G., Nguyen, N., Marks, G. (2020). A comparison of digital chest radiography and XpertW MTB/RIF in active case finding for tuberculosis. International Journal of Tuberculosis and Lung Disease, 24(9), 934-940.

Parker, M., Corte, T. (2020). First risk, next reward? A new clinico-radiological risk model predicts mortality in rheumatoid arthritis-associated interstitial lung disease. Respirology, 25(12), 1225-1226.

Piper, A., Lau, E. (2020). Positive airway pressure in obesity hypoventilation: Getting to the heart of the matter. American Journal of Respiratory and Critical Care Medicine, 201(5), 509-511.

Raghu, A., Wilson, K., Bargagli, E., Bendstrup, E., Chami, H., Chua, A., Chung, J., Collins, B., Corte, T., Dalphin, J., et al (2020). Diagnosis of hypersensitivity pneumonitis in adults: An official ATS/JRS/ALAT clinical practice guideline. American Journal of Respiratory and Critical Care Medicine, 202(3), E36-E69.

Rankin, N., Fradgley, E., Barnes, D. (2020). Implementation of lung cancer multidisciplinary teams: A review of evidence-practice gaps. Translational Lung Cancer Research, 9(4), 1667-1679.

Ratwatte, S., Anderson, J., Strange, G., Corrigan, C., Collins, N., Celermajer, D., Dwyer, N., Feenstra, J., Keating, D., Kotlyar, E., Lau, E., et al (2020). Pulmonary arterial hypertension with below threshold pulmonary vascular resistance. European Respiratory Journal, 56(1), 1901654.

Sivam, S., Poon, J., Wong, K., Yee, B., Piper, A., D'Rozario, A., Wang, D., Grunstein, R. (2020). Slow-frequency electroencephalography activity during wake and sleep in obesity hypoventilation syndrome. Sleep, 43(2), 1-9.

Sivam, S., Yee, B., Chadban, S., Piper, A., Hanly, P., Wang, D., Wong, K., Grunstein, R. (2020). Prevalence of chronic kidney disease in obesity hypoventilation syndrome and obstructive sleep apnoea with severe obesity. Sleep Medicine, 74, 73-77.

Standen, J., Morgan, G., Sowerbutts, T., Blazek, K., Gugusheff, J., Puntsag, O., Wollan, M., Torzillo, P. (2020). Prioritising housing maintenance to improve health in indigenous communities in NSW over 20 years. International Journal of Environmental Research and Public Health, 17(16), 1-22.

Suraev, A., Grunstein, R., Marshall, N., D'Rozario, A., Gordon, C., Bartlett, D., Wong, K., Yee, B., Vandrey, R., Irwin, C., Arnold, J., McGregor, I., Hoyos, C. (2020). Cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) for chronic insomnia disorder ('CANSLEEP' trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial. BMJ Open, 10(5), e034421.

Teoh, A., Corte, T. (2020). Nonspecific Interstitial Pneumonia. Seminars in Respiratory and Critical Care Medicine, 41(2), 184-201.

Teoh, A., Glaspole, I., Macansh, S., Corte, T. (2020). Importance of Occupational Exposure Data: A National Idiopathic Pulmonary Fibrosis Registry Perspective. American Journal of Respiratory and Critical Care Medicine, 201(9), 1165-1167.

Teoh, A., Jo, H., Chambers, D., Symons, K., Walters, E., Goh, N., Glaspole, I., Cooper, W., Reynolds, P., Moodley, Y., Corte, T. (2020). Blood monocyte counts as a potential prognostic marker for IPF: Analysis from the Australian IPF registry. European Respiratory Journal, 55(4), 1901855.

Thanh, H., Van, T., Thu, H., Van, B., Thanh, B., Thu, H., Kieu, A., Viet, N., Marks, G., Fox, G., Nguyen, T. (2020). Outbreak investigation for COVID-19 in northern Vietnam. The Lancet Infectious Diseases, 20(5), 535-536.

Tikellis, G., Lee, J., Corte, T., Maloney, J., Bartlett, M., Crawford, T., Glaspole, I., Goh, N., Herrmann, K., Hey-Cunningham, A., Spencer, L., Teoh, A., Walsh, J., et al (2020). Peer Connect Service for people with pulmonary fibrosis in Australia: Participants' experiences and process evaluation. Respirology, 25(10), 1053-1059.

Troy, L., Grainge, C., Corte, T., Williamson, J., Vallely, M., Cooper, W., Mahar, A., Myers, J., Lai, S., Mulyadi, E., Torzillo, P., Jo, H., Harris, B., Lau, E., et al (2020). Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study. The Lancet Respiratory Medicine, 8(2), 171-181

Wang, D., Phillips, C., Yee, B., Grunstein, R. (2020). Linking awake ventilatory chemosensitivity with opioid-induced respiratory depression during sleep-an important, but not a new, concept. Journal of Applied Physiology, 129(4), 932.

Wu, J., Wang, D., Rowsell, L., Wong, K., Yee, B., Nguyen, C., Han, F., Hilmisson, H., Thomas, R., Grunstein, R. (2020). The effect of acute exposure to morphine on breathing variability and cardiopulmonary coupling in men with obstructive sleep apnea: A randomized controlled trial. Journal of Sleep Research, 29(2), e12930.

2019

Bailey DL, Farrow CE, Lau EM. Normal values for lobar function and comparison with CT volumes. Sem Nuc Med 2019; 49:58-61

Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, Burgel PR, Tullis E, Castaños C, Castellani C, Byrnes CA, Cathcart F, Chotirmall SH, Cosgriff R, Eichler I, Fajac I, Goss CH, Drevinek P, Farrell PM, Gravelle AM, Havermans T, Mayer-Hamblett N, Kashirskaya N, Kerem E, Mathew JL, McKone EF, Naehrlich L, Nasr SZ, Oates GR, O'Neill C, Pypops U, Raraigh KS, Rowe SM, Southern KW, Sivam S, Stephenson AL, Zampoli M, Ratjen F. The Lancet Respiratory Medicine Commission on the Future of Care of Cystic Fibrosis. Lancet Respiratory Medicine 2019; 8(1):65-124.

Burgess A, Goon K, Brannan JD, Attia J, Palazzi K, Oldmeadow C, et al. Eligibility for anti-fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testing. Respirology. 2019;24(10):988-95.

Burgess A, Matar E, Neuen B, Fox GJ. A longitudinal faculty development program: Supporting a culture of teaching. BMC Medical Education. 2019;19(1).

Chang AB, Fong SM, Yeo TW, Ware RS, McCallum GB, Nathan AM, Ooi MH, de Bruyne J, Byrnes CA, Lee B, Nachiappan N, Saari N, Torzillo P, Smith-Vaughan H, Morris PS, Upham JW, Grimwood K. HOspitalised Pneumonia Extended (HOPE) Study to reduce the long-term effects of childhood pneumonia: protocol for a multicentre, double-blind, parallel, superiority randomised controlled trial. BMJ Open. 2019 Apr 24;9(4):e026411

Chemla D, Boulate D, Weatherald J, Lau EM, Attal P, Savale L, Montani D, Fadel E, Mercier O, Sitbon O, Humbert M, Hervé P. Golden ratio and the proportionality between pulmonary pressure components in pulmonary arterial hypertension. Chest 2018 (accepted)

Cho JG ,Teoh AKY, Roberts M, Wheatley J. The prevalence of poor sleep quality and its associated factors in patients with interstitial lung disease: a cross-sectional analysis. ERJ Open Res. 2019;5(3)

Chu CM, Piper A. Non-invasive ventilation: A glimpse into the future. Respirology. 2019 Dec;24(12):1140-1142

Culver DA, Behr J, Belperio JA, Corte TJ, De Andrade JA, Flaherty KR, et al. Patient registries in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine. 2019;200(2):160-7.

Dentice R, Elkins M, Verschuer J, Eberl S, Dwyer G, Bye P (2019). Side lying during nebulisation can significantly improve apical deposition in healthy adults and adults with mild cystic fibrosis lung disease: a randomised crossover trial. BMC Pulmonary Medicine 19:128

Doan TN, Fox GJ, Meehan MT, Scott N, Ragonnet R, Viney K, et al. Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: A decision analysis study. Journal of Antimicrobial Chemotherapy. 2019;74(1):218-27

Drabarek D, Anh NT, Nhung NV, Hoa NB, Fox GJ, Bernays S. Implementation of Medication Event Reminder Monitors among patients diagnosed with drug susceptible tuberculosis in rural Viet Nam: A qualitative study. PLoS ONE. 2019;14(7).

Dwyer TJ, Daviskas E, Zainuldin R, Verscuer J, Eberl S, Bye PTP, Alison J. Effects of exercise and airway clearance (PEP) on mucus clearance in cystic fibrosis: a randomised cross-over trial. 2019, European Respiratory Journal; 53:1801793.

E Joshi, B Nanayakkara, DJ Barnes and LK Troy. Precision medicine in lung cancer. European Medicine Journal. 2019.

Emery JD, Murray SR, Walter FM, Martin A, Goodall S, Mazza D, Habgood E, Kutzer Y, Barnes DJ, Murchie P. The CHEST Australia Trial: a randomised controlled trial of an intervention to increase consultation rates in smokers at risk of lung cancer. Thorax 2019;74:362-370.doi:10.1136/thoraxjnl-2018-212506

Fox GJ, Dodd PJ, Marais BJ. Household contact investigation to improve tuberculosis control. The Lancet Infectious Diseases. 2019;19(3):235-7.

Fox GJ, Nguyen VN, Dinh NS, Nghiem LPH, Le TNA, Nguyen TA, et al. Post-treatment mortality among patients with tuberculosis: A prospective cohort study of 10 964 patients in Vietnam. Clinical Infectious Diseases. 2019;68(8):1359-66

Goyal V, Grimwood K , Ware RS, Byrnes CA, Morris P, Masters BA, MCCullam GB, Binks MJ, Smith Vaughan H, O'Grady KA, Champion A, Buntain HA, Schultz A, Chatfield M, Torzillo PJ, Chang AB. Lancet Respiratory Medicine, 2019, Vol 7, 9: 791-801

Günther S, Perros F, Rautou PE, Girerd B, Ghigna MR, Cazals-Hatem D, Lau EM, Dorfmüller P, Sitbon O, Valla DC, Humbert M, Montani D. Understanding the Similarities and Differences between Hepatic and Pulmonary Veno-Occlusive Disease. Am J Pathol. 2019;189:1159-1175

Henderson D, Klebe S, Heinze SB, Miller A, Rouse HC, Duhig E, Cooper WA, Mahar AM, Ellis S, McCormack SR, Ng B, Godbolt DB, Corte TJ. Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis Registry.

Hoyos, C. M., Murugan, S. M., Melehan, K. L., Yee, B. J., Phillips, C. L., Killick, R., . . . Marshall, N. S. (2019). Dose-dependent effects of continuous positive airway pressure for sleep apnea on weight or metabolic function: Individual patient-level clinical trial meta-analysis. Journal of Sleep Research, 28(5) doi:10.1111/jsr.12788

Humbert M, Lau EMT. Should combination therapy be the standard of care in pulmonary arterial hypertension? Chest2019;156:1039-1042

Jee AS, Corte TJ. Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD). Drugs. 2019;79(14):1511-28.

Jee AS, Sahhar J, Youssef P, Bleasel J, Adelstein S, Nguyen M, et al. Review: Serum biomarkers in idiopathic pulmonary fibrosis and systemic sclerosis associated interstitial lung disease - frontiers and horizons. Pharmacol Ther 2019;202:40-52

Jo HE, Corte TJ, Glaspole I, Grainge C, Hopkins PMA, Moodley Y, Reynolds PN, Chapman S, Walters EH, Zappala C, Allan H, Keir GJ, Cooper WA, Mahar AM, Ellis S, Macansh S, Goh NS. Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry. BMC Pulm Med. 2019 May 3;19(1):84. doi: 10.1186/s12890-019-0846-2. PMID: 31053121; PMCID: PMC6499965

Jo HE, Glaspole I, Goh N, Hopkins PMA, Moodley Y, Reynolds PN, Chapman S, Walters EH, Zappala C, Allan H, Macansh S, Grainge C, Keir GJ, Hayen A,

Kendall EA, Sahu S, Pai M, Fox GJ, Varaine F, Cox H, et al. What will it take to eliminate drug-resistant tuberculosis? International Journal of Tuberculosis and Lung Disease. 2019;23(5):535-46.

Keshavjee S, Amanullah F, Cattamanchi A, Chaisson R, Dobos KM, Fox GJ, et al. Moving toward tuberculosis elimination critical issues for research in diagnostics and therapeutics for tuberculosis infection. American Journal of Respiratory and Critical Care Medicine. 2019;199(5):564-71.

LK Troy, C Grainge, TJ Corte, JP Williamson, MP Vallely, WA Cooper, et al. Cryobiopsy versus Open Lung biopsy in the Diagnosis of Interstitial lung disease (COLDICE): protocol of a multi-centre study. BMJ Open Respiratory Research. 2019; 6:e000443.

LK Troy, C Grainge, TJ Corte, JP Williamson, MP Vallely, WA Cooper, et al. Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study. The Lancet. Respiratory Medicine. 2019.

Lung T, Marks GB, Nhung NV, Anh NT, Hoa NLP, Anh LTN, et al. Household contact investigation for the detection of tuberculosis in Vietnam: economic evaluation of a cluster-randomised trial. The Lancet Global Health. 2019;7(3):e376-e84.

Maher TM, Stowasser S, Nishioka Y, White ES, Cottin V, Noth I, et al. Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study. The Lancet Respiratory Medicine. 2019;7(9):771-9.

Marks GB, Nguyen NV, Nguyen PTB, Nguyen TA, Nguyen HB, Tran KH, et al. Community-wide Screening for Tuberculosis in a High-Prevalence Setting. New England Journal of Medicine. 2019;381(14):1347-57.

Marshall, N. S., Serinel, Y., Killick, R., Child, J. M., Raisin, I., Berry, C. M., . . . Yee, B. J. (2019). Magnesium supplementation for the treatment of restless legs syndrome and periodic limb movement disorder: A systematic review. Sleep Medicine Reviews, 48 doi

Menadue C, Piper AJ. Pressuring stable patients with hypercapnic COPD to exercise. Respirology. 2019 Mar;24(3):195-196.

Milross MA, Piper AJ, Dwyer TJ, Bye PTP. Non-invasive ventilation versus oxygen therapy in cystic fibrosis: Long-term effects - Reply. Respirology. 2019 Dec;24(12):1222-1223

Milross MA, Piper AJ, Dwyer TJ, Wong K, Bell SC, Bye PTP for the Non-Invasive Ventilation in cystic fibrosis (NIVCF) study group. Non-invasive ventilation versus oxygen therapy in cystic fibrosis: A 12-month randomized trial. Respirology. 2019; 24:1191-1197.

Milross MA, Piper AJ, Dwyer TJ, Wong K, Bell SC, Bye PTP; Non-invasive ventilation versus oxygen therapy in cystic fibrosis: A 12-month randomized trial. Non-Invasive Ventilation in Cystic Fibrosis (NIVCF) Study Group. Respirology. 2019 Dec;24(12):1191-1197.

Mokhlesi B, Masa JF, Brozek JL, Gurubhagavatula I, Murphy PB, Piper AJ, Tulaimat A, Afshar M, Balachandran JS, Dweik RA, Grunstein RR, Hart N, Kaw R, Lorenzi-Filho G, Pamidi S, Patel BK, Patil SP, Pépin JL, Soghier I, Tamae Kakazu M, Teodorescu M. Evaluation and Management of Obesity Hypoventilation Syndrome. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2019 Aug 1;200(3):e6-e24.

Moodley YP, Corte TJ, Oliver BG, Glaspole IN, Livk A, Ito J, et al. Analysis by proteomics reveals unique circulatory proteins in idiopathic pulmonary fibrosis. Respirology 2019;24(11):1111-1114

Moodley YP, Corte TJ, Oliver BG, Glaspole IN, Livk A, Ito J, et al. Analysis by proteomics reveals unique circulatory proteins in idiopathic pulmonary fibrosis. Respirology. 2019;24(11):1111-4.

Moore C, Blumhagen RZ, Yang IV, Walts A, Powers J, Walker T, et al. Resequencing study confirms that host defense and cell senescence gene variants contribute to the risk of idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine. 2019;200(2):199-208.

Murphy PB, Piper AJ, Hart N. Obesity hypoventilation syndrome: is less really more? Lancet. 2019 Apr 27;393(10182):1674-1676.

Murray JM, Phillips AJK, Magee M, Sletten TL, Gordon C, Lovato N, Bei B, Bartlett DJ, Kennaway DJ, Lack LC, Grunstein RR, Lockley SW, Rajaratnam SMW, Delayed Sleep on Melatonin (DelSoM) Study Group. Sleep regularity is associated with sleep-wake and circadian timing, and mediates daytime function in Delayed Sleep-Wake Phase Disorder. Sleep Med 2019 58:93-101

Nathan SD, Behr J, Collard HR, Cottin V, Hoeper MM, Martinez FJ, et al. Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study. The Lancet Respiratory Medicine. 2019;7(9):780-90.

Noth I, Wijsenbeek M, Kolb M, Bonella F, Moros L, Wachtlin D, et al. Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the TOMORROW and INPULSIS trials. The European respiratory journal. 2019;54(3).

Oxlade O, Trajman A, Benedetti A, Adjobimey M, Cook VJ, Fisher D, et al. Enhancing the public health impact of latent tuberculosis infection diagnosis and treatment (ACT4): Protocol for a cluster randomised trial. BMJ Open. 2019;9(3).

Phuong NTB, Anh NT, Van Son N, Sintchenko V, Ho J, Fox GJ, et al. Effect of two alternative methods of pooling sputum prior to testing for tuberculosis with genexpert MTB/RIF. BMC Infectious Diseases. 2019;19(1).

Piper A, Chu CM. Non-invasive ventilation: Inspiring clinical practice. Respirology. 2019 Apr;24(4):306-307.

Poon, J. J. Y., Chapman, J. L., Wong, K. K. H., Mullins, A. E., Cho, G., Kim, J. W., . . . D'Rozario, A. L. (2019). Intra-individual stability of NREM sleep quantitative EEG measures in obstructive sleep apnea. Journal of Sleep Research, 28(6) doi:10.1111/jsr.12838

Rankin NM, Fradgley EA, Barnes DJ. Implementation of lung cancer multidisciplinary teams: a review of evidence-practice gaps. Transl Lung Cancer Res 2019 http://dx.doi.org/10.21037/tlcr.2019.11.32

Respirology. 2019 Apr;24(4):361-368. doi: 10.1111/resp.13427. Epub 2018 Oct 17. PMID: 30328644.

Romanowski K, Baumann B, Basham CA, Ahmad Khan F, Fox GJ, Johnston JC. Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis. The Lancet Infectious Diseases. 2019;19(10):1129-37.

Rowsell, L., Wong, K. K. H., Yee, B. J., Eckert, D. J., Somogyi, A. A., Duffin, J., . . . Wang, D. (2019). The effect of acute morphine on obstructive sleep apnoea: A randomised double-blind placebo-controlled crossover trial. Thorax, 74(2), 177-184. doi:10.1136/thoraxjnl-2018-211675

Sake, F. -. -., Wong, K., Bartlett, D. J., & Saini, B. (2019). Benzodiazepine usage and patient preference for alternative therapies: A descriptive study. Health Science Reports, 2(5) doi:10.1002/hsr2.116

Sake, F. -. -., Wong, K., Bartlett, D. J., & Saini, B. (2019). Benzodiazepine use risk: Understanding patient specific risk perceptions and medication beliefs. Research in Social and Administrative Pharmacy, 15(11), 1317-1325. doi:10.1016/j.sapharm.2018.12.007

Sake, F. -. -., Wong, K., Bartlett, D. J., & Saini, B. (2019). Insomnia management in the australian primary care setting. Behavioral Sleep Medicine, 17(1), 19-30. doi:10.1080/15402002.2016.1266491

Serinel, Y., Hoyos, C., Qasem, A., Yee, B. J., Grunstein, R. R., Wong, K. H., & Phillips, C. L. (2019). Diurnal changes in central blood pressure and pulse pressure amplification in patients with obstructive sleep apnoea. International Journal of Cardiology: Hypertension, 1 doi:10.1016/j.ijchy.2019.100002

Sutherland, K., Chapman, J. L., Cayanan, E. A., Lowth, A. B., Wong, K. K. H., Yee, B. J., . . . Cistulli, P. A. (2019). Parsing the craniofacial phenotype: Effect of weight change in an obstructive sleep apnoea population. Sleep and Breathing, 23(4), 1291-1298. doi:10.1007/s11325-019-01826-2

Theorell-Haglow J, Hoyos CM, Phillips CL, Yee BJ, Melehan KL, Liu PY, Cistulli PA, Grunstein RR. Associations between obstructive sleep apnea and measures of arterial stiffness. JCSM 2019 15(2):201-6

Troy, L. K., Young, I. H., Lau, E. M. T., Wong, K. K. H., Yee, B. J., Torzillo, P. J., & Corte, T. J. (2019). Nocturnal hypoxaemia is associated with adverse outcomes in interstitial lung disease. Respirology, 24(10), 996-1004. doi:10.1111/resp.13549

Visser SK, Bye PT, Fox G, et al. Australian adults with bronchiectasis: the first report from the Australian Bronchiectasis Registry. Respir Med 2019; 155: 97-103.

Visser SK, Bye PT, Fox G, et al. Management of Australian adults with bronchiectasis in tertiary care - evidence-based or access-driven? Lung. 2019, 197, 803-810.

Walsh SLF, Lederer DJ, Ryerson CJ, Kolb M, Maher TM, Nusser R, et al. Diagnostic likelihood thresholds that define a working diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2019;200(9):1146-1153

Wang D, Yee BJ, Grunstein RR. Does sleep apnea worsen the adverse effects of Opioids and Benzodiazepines on Chronic Obstructive Pulmonary Disease? Ann Am Thorac 2019 16(10):1237-38

Wigger C, Leach AJ, Beissbarth J, Oguoma V, Lennox R, Nelson S, Patel H, Chatfield M, Currie K, Coates H, Edwards K, Smith-Vaughan H, Hare K, Torzillo P, Tong S, Morris P. Povidone-iodine ear wash and oral cotrimoxazole for chronic suppurative otitis media in Australian aboriginal children: study protocol for factorial design randomised controlled trial. BMC Pharmacol Toxicol. 2019 Jul 27;20(1):46.

Wong, E. K. C., Lee, P. C. S., Ansary, S., Asha, S., Wong, K. K. H., Yee, B. J., & Ng, A. T. (2019). Role of venous blood gases in hypercapnic respiratory failure chronic obstructive pulmonary disease patients presenting to the emergency department. Internal Medicine Journal, 49(7), 834-837. doi:10.1111/imj.14186

Respiratory Medicine Research

Selected Grants

Our Publications

2022

Respiratory Medicine Research

Respiratory Medicine Research

Our Organisation

Make a Donation

Our Hospitals

Right to Information

Plans

Publications

Quick Links